Ruti Aga's Six-Year Ban: The Forged Prescription Cost Her the Defence That Was Genuinely Available
core_answer: रुति अगा को एथलेटिक्स इंटीग्रिटी यूनिट (AIU) ने छह साल का प्रतिबंध दिया — दो साल मिथाइलप्रेडनिसोलोन की मौजूदगी के लिए, चार साल नकली प्रिस्क्रिप्शन और भ्रामक जानकारी के लिए। यह पदार्थ एनाबॉलिक स्टेरॉयड नहीं, WADA श्रेणी S9 का ग्लूकोकार्टिकोइड है, जो केवल प्रतियोगिता के दौरान प्रतिबंधित है।
key_facts: 32 वर्षीय इथियोपियाई मैराथन धाविका रुति अगा ने मार्च में चीन में हाफ मैराथन जीती; इसके बाद लिया गया नमूना सकारात्मक पाया गया।; प्रतिबंध 10 सितंबर से प्रभावी है, जिस तारीख़ से उनका अस्थायी निलंबन चल रहा था।; पर्चा परिवार के एक सदस्य ने लिखा, जिसका कोई मेडिकल रजिस्ट्रेशन नहीं था; पर्चे पर अंकित क्लिनिक का अस्तित्व ही नहीं था।; अगा 2019 टोक्यो मैराथन विजेता हैं और तीन वर्ल्ड मैराथन मेजर में दूसरा स्थान पा चुकी हैं।; छह साल की सज़ा से 2028 ओलंपिक चक्र समाप्त; वापसी की संभावित उम्र लगभग 38 वर्ष होगी।
source: स्रोत: एथलेटिक्स इंटीग्रिटी यूनिट (AIU) का गुरुवार को जारी आधिकारिक बयान; तारीख़ें और मार्च की दौड़ का उल्लेख उसी बयान में दर्ज है।
related_qa: q: क्या मिथाइलप्रेडनिसोलोन प्रतिबंधित स्टेरॉयड है?, a: नहीं — यह WADA सूची की श्रेणी S9 का ग्लूकोकार्टिकोइड है और केवल प्रतियोगिता के दौरान, इंजेक्शन/मुँह/रेक्टल मार्ग से प्रतिबंधित है।; q: छह साल की सज़ा कैसे बनी?, a: मौजूदगी के उल्लंघन पर दो साल और छेड़छाड़ (नकली पर्चा व भ्रामक बयान) पर चार साल मिलाकर कुल छह साल, जो 10 सितंबर से गिने जाते हैं।; q: क्या अगा के 2019 टोक्यो खिताब पर असर पड़ेगा?, a: बयान में पुराने रिज़ल्ट रद्द होने का उल्लेख नहीं है; मार्च वाली दौड़ का नतीजा और इनामी रकम रद्द होने की संभावना सबसे अधिक है।
I watched the last two kilometres of the Tokyo Marathon on a laptop. It was 5:30 in the morning in Mumbai, the tea had gone cold, and there were three cricket files on the desk. 3 March 2026. Ruti Aga won that race in 2:20:40 — a 25-year-old Ethiopian with her first World Marathon Major title. Our desk gave the story ninety words next morning. Wire copy. No byline. No phone call to anyone.

Seven years later, on a Thursday afternoon, the Athletics Integrity Unit (AIU) issued a statement and the same name surfaced as a headline. Six years. The athlete who got ninety words for winning now got a full bulletin for being banned.
For eighteen years on the track and road-running beat I have kept a private ledger — who got space, who got words, and whose money stood behind the space. The ledger keeps saying the same thing: we cover the noise around sport, not the sport. Ruti Aga is its cleanest entry. The win went unrecorded. The ban got recorded.
This piece is not about that grievance. It is about what sits inside the AIU statement and disappears in headlines: the classification of the substance, the arithmetic of the sanction, and a prescription that no clinic ever wrote.
Start with the record, because without it the size of the sanction makes no sense. Aga was second at the 2026 Berlin Marathon in 2:18:34, twenty-three seconds behind Gladys Cherono. She won Tokyo in 2026 in 2:20:40. Three second places at World Marathon Majors. That is a genuine elite career, built in a country where the top end of women's marathoning has now gone under 2:11. A 2:18–2:20 runner is Ethiopia's fourth or fifth option; in almost any other country she would be an Olympic medal contender.
Now the statement. According to the AIU, Aga won a half marathon in China in March and the sample collected afterwards returned methylprednisolone. She cited a knee injury. The prescription produced in evidence was written by a family member with no medical registration, who claimed to have used an old prescription pad from a former workplace. The clinic named on the document could not be found, and disowned the pad. The outcome: two years for the presence violation, four years for tampering. Six in total, running from 10 September — the date her provisional suspension began. The statement does not spell out the year, but the dates add up.
First, a technical correction, because the whole case rests on it: methylprednisolone is not an anabolic steroid. It is a glucocorticoid — WADA Prohibited List class S9 — and it is prohibited in-competition only, by injection, oral or rectal route. Anabolic steroids sit in class S1 and are banned at all times. Several media reports called it a steroid. That description is wrong, and a wrong description distorts how the sanction reads.
The difference is entirely practical. A glucocorticoid injection for knee synovitis in a marathoner is routine, documentable sports medicine. Out of competition it is legal. It becomes a violation only if residues are present in-competition. So the case was never about the drug. It was about timing and route. The defence was real: genuine treatment records, the injection date, the route, and a Therapeutic Use Exemption if required.
The forged prescription closed that route. The real story is that the heaviest part of this sanction fell on the lie, not on the drug. Two years fits the pattern where the substance is Specified and intent is not proven. Four years is the Code's standard tampering sanction. Together they make six — and the sum also tells us the panel refused the no-significant-fault mitigation. With genuine records, the argument would have swirled around two years, and no tampering charge would have existed.
Three separate points of verification collapsed. One, the clinic did not exist. Two, the person who wrote the prescription held no registration. Three, the clinic explicitly disowned the pad. That is three independent failures; any one of them holding would have kept the defence alive. And a fourth point that gets missed: the tampering charge came partly from statements made under interview, not from the document alone. What was said in the room became part of the sanction.
This is where the map of the sport shifts. Across AIU road-running cases there is a recognisable pattern: a substance violation first, then a second violation about evidence — an altered document, a manufactured explanation, misleading information. The enforcement frontier has moved from detection to document verification. That is not a small shift. When anti-doping work reaches the authenticity of paperwork, the centre of gravity of a sanction moves off the chemistry and onto trust.
And that crisis of trust is connected to money. Chinese label road races have long been a high-appearance-fee, low-risk income tier for East African marathoners — a comfortable cash flow between Majors. The same tier is now the AIU's densest testing ground. The appearance-fee economy and the testing economy are colliding in the same races. Aga's case is a product of that collision, and its weakest link is the one nobody looks at: the medical staff around the athlete.
One truth needs stating plainly, or this becomes a morality tale. An athlete with a credentialed team doctor does not commission a fake prescription — she keeps treatment records, applies for a TUE, or observes the washout interval between injection and race. None of the three appears in Aga's case. What appears is a family member, an old pad, and a clinic that existed on paper but not on the ground. That is less an individual lapse than a structural vacuum: medical support in that racing corridor is often informal, and informality becomes documentary crime.
The career arithmetic is merciless. Aga is 32. Six years from 10 September puts a possible return at roughly 38. Against the depth of Ethiopian women's marathoning, a 38-year-old with a doping record is effectively unselectable. For a 32-year-old, six years is not a ban; it is the end of a career. The 2028 Olympic cycle was never really hers — the ban only made it official.
The media's error here is ethical before it is technical. Filing a glucocorticoid as a 'steroid' places the case in a queue with testosterone, EPO and blood doping, when the actual question was why residue from a knee injection was present on race day.
Now the uncomfortable part. It is easy to assume six years is this story's natural ending. I don't think it is — at least not in the way it has been presented.
On one side, the AIU's position is clear and strong: a forged document is deliberate, and softness on it tells the whole system that lying is cheap. Fair enough — four years for tampering is the Code's standard, and nothing in this file justifies reducing it.
On the other, two things unsettle. First, the substance that cost two years has no proven endurance benefit. The weight fell on the lie — which is both right and wrong. Right, because the system must protect itself from documentary deceit. Wrong, because the message becomes: treating an injury is fine, but faking the paperwork is what costs you. Second, and more pointed — the statement names only the family member. Where was the agent? Where was the management? No charge attaches to whoever advised that the document be produced. The Ethiopian federation is not quoted at all. A 32-year-old's career ended over a three-year-old piece of paper, and nobody who advised on that paper has stepped forward.
That is not an accusation; it is a pointer at empty space. I know that in these cases the people who answer are the ones I will have to call again — which is why I am not naming them, only counting. And the count says the sanction reached one person while three parts of the system — medicine, management, federation — stayed silent.
The question in the mixed zone is always the same: who gets heard? At Kalinga I was the only woman in the mixed zone, and the only one listening for the second story. Here the second story is that with one genuine medical record, this article would not exist.
The time from that Chinese half marathon is not in the statement. She won, it says; in what mark, it does not. The mark nobody filed is the truest picture of this whole affair — we know where she won, not how fast she ran, and we know in full detail which document she produced. The race result became trivial; the paperwork result became terminal. The stat sheet ends where the athlete begins.
One more clarification, because a piece that ends on 'the ban is too harsh' would be useless. I do not believe in giving both sides equal space on fairness. Here the facts are these: a clinic that did not exist, a doctor who was not registered, a pad its owner disowned — all three are established. That is not debatable. The severity is debatable; the basis is not.
And the argument that gets lost in that debate is the one that matters: the future. When she is 38 and reads an entry list, a 22-year-old in the same stable will have a swollen knee. She will have two routes — a registered doctor, or an old pad. This case priced the second route. Nobody's agenda appears to include providing the first.
The CAS appeal window closes in about three weeks. Document-based findings do not get overturned. That March result and its prize money will be annulled, ranking points will go, and the 2026 Tokyo title will stay in the record book with nobody remembering it. Six years from now, when she counts back to a return date, the question will not be what she took. It will be who she had to call.
